SCHEMBL4831799

SCHEMBL4831799

Cc1noc([C@H](N)Cc2ccccc2-c2ccc(F)c(Cl)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.40
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
FYN P06241 1/20 0.34
EPHB4 P54760 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
MME P08473 1/20 0.33
GRIN2B Q13224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4829811 0.99 DPP4 (0.39) DPP4PTGS2PTGS1ADORA2AADORA1
Hydrochloric Acid SCHEMBL4829817 0.99 DPP4 (0.39) DPP4PTGS2PTGS1ADORA2AADORA1
SCHEMBL3996630 0.82 DPP4 (0.38) DPP4DPP8NISCHGRIN2B
SCHEMBL4827765 0.82 DPP4 (0.38) DPP4DPP8NISCHGRIN2B
SCHEMBL4829751 0.82 TP53 (0.37) DPP4ADORA2AADORA1TP53MAPT
Hydrochloric Acid SCHEMBL4831560 0.81 DPP4 (0.37) DPP4DPP8NISCHGRIN2B
Hydrochloric Acid SCHEMBL4831555 0.81 DPP4 (0.37) DPP4DPP8NISCHGRIN2B
Hydrochloric Acid SCHEMBL4829588 0.81 TP53 (0.37) DPP4ADORA2AADORA1EPHB4TP53
Hydrochloric Acid SCHEMBL4829583 0.81 TP53 (0.37) DPP4ADORA2AADORA1EPHB4TP53
SCHEMBL6529226 0.78 DPP4 (0.39) DPP4DPP8MMEGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459472-B2 Aryl and heteroaryl compounds, compositions, and methods of use TRANSTECH PHARMA, INC. (US) 2008-12-02 US disclosed
US-20050059713-A1 Aryl and heteroaryl compounds, compositions, and methods of use VTVX HOLDINGS I LLC 2005-03-17 US disclosed
WO-2005014534-A1 ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE TRANSTECH PHARMA, INC. (US) 2005-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059713-A1 Aryl and heteroaryl compounds, compositions, and methods of use CYP2F1, CYP3A43, PNPO DPP4 1658/4885PTGS2 3634/4885PTGS1 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.